American private equity firm The Carlyle group on Friday made a complete exit from its investment in diagnostic chain Metropolis Healthcare Ltd, selling its residual stake in the company for around ₹84 crore, through block deals on the stock exchanges.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
